Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Akira MitsuhashiYohei KawasakiMakoto HoriTadami FujiwaraHideki HanaokaMakio ShozuPublished in: BMJ open (2020)
Japan Registry of Clinical Trials (jRCT2031190065).